Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Session

Published 18/10/2022, 17:43
Updated 18/10/2022, 19:12
© Reuters.  Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Session

Gainers

  • Akouos, Inc. (NASDAQ: AKUS) shares jumped 89.4% to $13.27. Eli Lilly And Co (NYSE: NYSE:LLY) agreed to acquire Akouos for a 78% premium over Monday’s closing price of $7.01.
  • Zovio Inc (NASDAQ: ZVO) rose 85.4% to $0.2674 after declining 11% on Monday.
  • Helbiz, Inc. (NASDAQ: HLBZ) gained 82.2% to $0.4855. Helbiz CEO Salvatore Palella recently acquired a total of 200,000 shares at an average price of $0.25.
  • COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 55.4% to $0.0687 after gaining 4% on Monday.
  • Eqonex Limited (NASDAQ: EQOS) gained 53.3% to $0.40.
  • Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares climbed 43.5% to $8.84. Kiora Pharmaceuticals, on Monday, announced publication of Phase 1 trial results for KIO-100 as a treatment for ocular inflammatory disease.
  • AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) gained 40.7% to $14.75 after LG Chem announced it will acquire AVEO Oncology for $15 per share in cash.
  • Bright Minds Biosciences Inc. (NASDAQ: DRUG) surged 40% to $1.3999.
  • Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) gained 36% to $2.57 after the company announced plans to initiate a second clinical trial in Netherton Syndrome patients.
  • Rubicon Technologies, Inc. (NYSE: RBT) jumped 32.7% to $1.46.
  • Decibel Therapeutics, Inc. (NASDAQ: DBTX) rose 27.1% to $3.75. Decibel Therapeutics recently received FDA clearance of IND application for DB-OTO, a gene therapy product candidate designed to provide hearing to individuals with otoferlin-related hearing loss.
  • Liquid Media Group Ltd. (NASDAQ: YVR) jumped 19.3% to $0.3581 after the company announced Q3 sales were up year over year.
  • Ra Medical Systems, Inc. (NYSE: RMED) shares gained 17% to $6.37. Ra Medical Systems raised $7.6 million through completed at-the-market facility.
  • IAMGOLD Corporation (NYSE: IAG (LON:ICAG)) rose 15% to $1.2250 after the company announced an agreement to sell its interest in Rosebel Gold Mines to Zijin Mining for cash consideration of $360 million.
  • Eterna Therapeutics Inc. (NASDAQ: ERNA) surged 13% to $5.60.
  • NextPlay Technologies, Inc. (NASDAQ: NXTP) gained 10% to $0.2201. NextPlay Technologies recently announced its NextBank secured a $200,000,000 revolving credit line facility.
  • Carnival Corporation (NYSE: NYSE:CCL) rose 8.3% to $7.88 amid strength in cruise stocks. The company earlier announced a private offering of $1.25 billion aggregate principal amount of Senior Priority Notes due 2028.
  • Tremor International Ltd (NASDAQ: TRMR) rose 7.1% to $7.71 after gaining 9% on Monday.
Losers
  • Cosmos Holdings Inc. (NASDAQ: COSM) dropped 46% to $0.0805 after the company announced pricing of a $7.5 million upsized public offering at $0.12 per share.
  • Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) shares dipped 40.6% to $2.97 after the company announced a pause in new patient enrollment in its Phase 1/2 trial of seclidemstat in Ewing Sarcoma and FET-rearranged sarcomas following the death of a patient.
  • Agrify Corporation (NASDAQ: AGFY) fell 39.4% to $6.48. Agrify said its Board of Directors approved a 1-for-10 reverse stock split.
  • Inpixon (NASDAQ: INPX) fell 34.8% to $5.94. The company recently announced new purchase orders.
  • Sierra Metals Inc. (NYSE: SMTS) dropped 32.6% to $0.33 after the company provided a financial and operations update and announced a strategic review process.
  • American Virtual Cloud Technologies, Inc. (NASDAQ: AVCT (LON:AVCT)) dipped 25% to $1.6799. AVCT reported a $10 million registered direct offering and concurrent private placement priced at-the-market under Nasdaq rules.
  • 9 Meters Biopharma, Inc. (NASDAQ: NMTR) fell 23% to $2.74. 9 Meters Biopharma announced a 1-for-20 reverse stock split.
  • Venus Acquisition Corporation (NASDAQ: VENA) dropped 22.5% to $8.01.
  • Acorda Therapeutics, Inc. (NASDAQ: ACOR) shares fell 22.3% to $0.6963. Acorda Therapeutics shares surged 164% on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
  • Statera Biopharma, Inc. (NASDAQ: STAB) shares fell 22.2% to $0.1670 after jumping 35% on Monday. Statera Biopharma announced signing of a binding MOU with Holobeam Technologies to gain access to Holobeam's disruptive diagnostic imaging and therapeutic technology for cancer patients.
  • Silvergate Capital Corporation (NYSE: SI) dropped 21% to $55.98 after the company reported worse-than-expected Q3 EPS and sales results.
  • FLJ Group Limited (NASDAQ: FLJ) fell 20% to $1.57.
  • Dragonfly Energy Holdings Corp. (NASDAQ: DFLI) fell 20% to $7.66 after jumping 26% on Monday.
  • Xtant Medical Holdings, Inc. (NYSE: XTNT) dropped 17.7% to $0.6583.
  • authID Inc. (NASDAQ: AUID) fell 14.6% to $1.41.
  • Vigil Neuroscience, Inc. (NASDAQ: VIGL) dropped 11.8% to $13.26.
  • Forge Global Holdings, Inc. (NASDAQ: FRGE) shares fell 7.8% to $1.6227 after gaining 21% on Monday.
  • Nuwellis, Inc. (NASDAQ: NUWE) shares fell 7.3% to $0.2780 after surging 15% on Monday. Nuwellis recently announced pricing of $9.6 million upsized underwritten public offering.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.